MARSHALL WACE, LLP - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q4 2022$26,176
-45.5%
20,775
-31.2%
0.00%
Q3 2022$48,000
+14.3%
30,175
+40.4%
0.00%
Q2 2022$42,000
-98.6%
21,486
-94.7%
0.00%
-100.0%
Q2 2021$2,953,000
+4242.6%
406,401
+9225.4%
0.01%
+1200.0%
Q1 2020$68,000
+83.8%
4,358
+112.4%
0.00%
Q3 2019$37,000
-87.6%
2,052
-86.5%
0.00%
-100.0%
Q2 2019$298,000
+101.4%
15,241
+185.4%
0.00%
+100.0%
Q1 2019$148,0005,3400.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders